Inventor · disambiguated record
Soo S. Ko
Also filed as: KO SOO · KO SOO S · KO SOO SUNG
41 granted patents·5 pending applications·736 citations·filing 1990–2019
98Inventor score
Files withBRISTOL MYERS SQUIBB PHARMA CO16BRISTOL MYERS SQUIBB CO13DU PONT MERCK PHARMA4DU PONT2DU PONT PHARM CO2
Top patents by PatentIndex Score
46 records- 0195US6525069B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 25, 2003·52 cites·28 claims
- 0294US5874430A4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 1997·Granted Feb 23, 1999·87 cites·22 claims
- 0392US6331541B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 1999·Granted Dec 18, 2001·57 cites·42 claims
- 0491US6759411B2Heterocyclic piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 6, 2004·26 cites·45 claims
- 0591US6521592B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Feb 18, 2003·28 cites·16 claims
- 0690US5583147AAmides for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1994·Granted Dec 10, 1996·49 cites·33 claims
- 0789US7163937B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jan 16, 2007·29 cites·19 claims
- 0889US6605623B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Aug 12, 2003·36 cites·27 claims
- 0988US5491152ADerivatives of cyclic ethers and sulfides for the treatment of atherosclerosisDU PONT MERCK PHARMA·Filed 1994·Granted Feb 13, 1996·40 cites·15 claims
- 1085US9334290B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 10, 2016·5 cites·20 claims
- 1184US7482335B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 27, 2009·6 cites·21 claims
- 1284US6949546B2N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Sep 27, 2005·18 cites·15 claims
- 1384US6627629B2N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA·Filed 2001·Granted Sep 30, 2003·20 cites·24 claims
- 1482US6441001B12-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Aug 27, 2002·26 cites·59 claims
- 1582US6124302A4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitorsDU PONT PHARM CO·Filed 1998·Granted Sep 26, 2000·23 cites·54 claims
- 1681US5683999ACyclic urea HIV protease inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Nov 4, 1997·29 cites·18 claims
- 1780US5041432ASteroid derivatives useful as hypocholesterolemicsDU PONT·Filed 1990·Granted Aug 20, 1991·39 cites·74 claims
- 1879US6444686B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRSITOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Sep 3, 2002·58 cites·49 claims
- 1978US6331545B1Heterocycyclic piperidines as modulators of chemokine receptor activityFiled 1999·Granted Dec 18, 2001·18 cites·53 claims
- 2077US7550486B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 23, 2009·2 cites·7 claims
- 2175US6780857B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Aug 24, 2004·6 cites·27 claims
- 2272US6492400B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Dec 10, 2002·15 cites·23 claims
- 2371US7351720B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 1, 2008·4 cites·9 claims
- 2470US9216972B2Tricyclic heterocyclic compoundsDHAR T G MURALI·Filed 2010·Granted Dec 22, 2015·2 cites·16 claims
- 2570US6423718B14,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jul 23, 2002·3 cites·20 claims
- 2669US9714234B2Carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 25, 2017·1 cites·9 claims
- 2768US9187437B2Substituted oxadiazole compoundsDAS JAGABANDHU·Filed 2011·Granted Nov 17, 2015·1 cites·7 claims
- 2868US6897234B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted May 24, 2005·3 cites·26 claims
- 2968US6706735B22-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 16, 2004·3 cites·35 claims
- 3067US10435415B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 8, 2019·0 cites·11 claims
- 3167US6919368B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jul 19, 2005·3 cites·15 claims
- 3267US6906066B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 14, 2005·3 cites·31 claims
- 3367US6875776B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Apr 5, 2005·3 cites·22 claims
- 3467US5219879AHeterocyclic steroid compoundsDU PONT MERCK PHARMA·Filed 1991·Granted Jun 15, 1993·19 cites·58 claims
- 3567US2019382416A1Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 3666US6486180B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Nov 26, 2002·10 cites·32 claims
- 3765US10106559B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·0 cites·11 claims
- 3863US7829571B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 9, 2010·0 cites·18 claims
- 3963US7291744B2N-ureidoalkyl-amino compounds as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 6, 2007·2 cites·22 claims
- 4057US2016194338A1Substituted tetrahydrocarbazole and carbazoles carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 4153US7312222B2Heterocyclic piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Dec 25, 2007·0 cites·43 claims
- 4253US2005192291A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 2004·Application pending·0 cites
- 4352US5034548ASteroid derivatives useful as hypocholesterolemicsDU PONT·Filed 1990·Granted Jul 23, 1991·10 cites·69 claims
- 4451US2005096325A1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityFiled 2004·Application pending·0 cites
- 4549US7687508B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 30, 2010·0 cites·11 claims
- 4649US2003092722A14,4-disubstituted-3,4-dihydro-2(1H)-quinazolines useful as HIV reverse transcriptase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soo S. Ko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →